MSACL 2018 US Abstract

Topic: Practical Training

Getting Started with Pharmacogenetics Testing and Mass Spectrometry - III

Fang Wu (Presenter)
St. Paul Hospital, Saskatoon Health Region

Authorship: Fang Wu(1), Roberta Melis (2), Gwendolyn A. McMillin (2,3)
(1) Department of Laboratory Medicine and Pathology, Saskatoon Health Region, Saskatoon, SK, Canada, S7W 0S1; (2) ARUP Laboratories, Salt Lake City, UT, USA, 84108; (3) Department of Pathology, University of Utah, Salt Lake City, UT,USA, 84132,

Short Abstract

The last 20-minute segment will cover method validation/evaluation for MALDI-TOF/MS PGx testing. Recommendations on accuracy, method comparison, reproducibility (within run and between run), sensitivity, carryover and specimen requirements will be given.

Long Abstract

Introduction

N/A

Methods

N/A

Results

N/A

Conclusions & Discussion

After this segment, participants will be able to create a method validation plan.


References & Acknowledgements:

N/A


Financial Disclosure

DescriptionY/NSource
Grantsno
Salaryno
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no